companydata.dkDRIVI ApS: Financial statements 2018
CVR: 36201266
DRIVI ApS (CVR 36201266) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 55,728 and a net result of DKK 24,518 compared with DKK -190 the year before. That is an increase of 107.3% compared with the year before. The profit margin was 44%. Equity amounted to DKK 23,004. The solvency ratio was 67%.
- Revenue
- 55,728 kr.
- Gross Profit
- 55,728 kr.
- Profit/Loss
- 24,518 kr.
- Equity
- 23,004 kr.
- Total Assets
- 34,334 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 56 t. | 56 t. | 25 t. | 23 t. | - |
| 2017 | 27 t. | 27 t. | -190 | 2 t. | - |
| 2016 | - | -239 | 1 | 1 | - |
| 2015 | - | -98 | -101 | -3 t. | - |
Keep an eye on DRIVI ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of December 19, 2018, Guido Helmut Seitz has left the board of directors of DRIVI ApS.
As of December 9, 2018, Uffe Schjorterich Skotte has stepped down as director of DRIVI ApS.
As of December 9, 2018, Uffe Schjorterich Skotte has stepped down as chairman of DRIVI ApS.
As of June 25, 2018, Kasper Tikjøb has joined the board of directors of DRIVI ApS.
As of June 25, 2018, Oliver Thor Sørensen has joined the board of directors of DRIVI ApS.
As of June 25, 2018, Guido Helmut Seitz has joined the board of directors of DRIVI ApS.
As of June 25, 2018, Oliver Thor Sørensen is registered as adm. dir. of DRIVI ApS.
As of June 25, 2018, Uffe Schjorterich Skotte is registered as chairman of DRIVI ApS.
On June 25, 2018, the company changed its name from VIRIDOC IVS to DRIVI IVS.
As of June 24, 2018, Oliver Thor Sørensen has stepped down as director of DRIVI ApS.
About DRIVI ApS
DRIVI ApS was a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2014. The company was registered under the industry Computerprogrammering. The company was previously named DRIVI IVS and VIRIDOC IVS. In 2023, the company reported a gross profit of DKK 651,774 and a net result of DKK 82,020 compared with DKK 31,838 the year before. Equity amounted to DKK 76,497.